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Abstract 
Staphylococcus aureus is recognized as the leading cause of nosocomial infections in 
the hospitals and healthcare settings. This bacterium can cause a broad spectrum of 
infection such as skin, soft tissue, respiratory infections and sepsis. Its ability to rapidly 
develop resistance to antimicrobial compounds by horizontal gene transfer (HGT) has been 
the global concern. There are three major mechanisms responsible for HGT in bacteria: 
conjugation, transduction and transformation. Conjugation is responsible for the transfer of 
DNA from one living cell to another through the direct contact allowing the DNA to be 
exchanged while being protected by special structure, such as tubes or pores. Conjugation 
is not widespread in S. aureus. Transduction is the process in which DNA is transferred by 
bacterial virus (bacteriophage), and is considered as the major route to acquire new DNA in 
S. aureus. However, phage transduction has the limitation in the size of DNA to be 
transferred (< 45 kb). Transformation is the direct uptake of free DNA by the cells that 
developed the “competence” stage. Natural transformation in S. aureus was recently 
described by our group.  
In this thesis, I describe the researches to elucidate the resistance acquisition through 
the HGT in S. aureus. The thesis consists of four chapters. In Chapter 1, general 
introduction of S. aureus with the attention to the major issue of drug resistance was 
described. Later part in this chapter focused on the HGT and the recent discovery of 
natural transformation in S. aureus. 
In Chapter 2, the impact of HGT pathways in the spread of resistance among S. 
aureus, and between S. aureus and other staphylococci species was evaluated. In this work, 
we investigated the dissemination of cfr (chloramphenicol/florfenicol resistance) gene, 
which is responsible for the resistance to linezolid, the emerging problem of resistant S. 
aureus.  
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In Chapter 3, the investigations to unravel the factor(s) affecting on natural 
transformation in S. aureus are summarized. Here, I found that antibiotics have distinct 
effects on transformation; some drugs that target on the bacterial cell wall could increase 
transformation frequencies. Thus, the results raise a caution regarding medical prescription 
in the treatment of S. aureus considering the induction of HGT.  
Finally, summary of the studies and future directions of the investigations on natural 
competence and transformation in S. aureus are discussed in the last chapter (Chapter 4). 
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List of Abbreviations 
 
AIDS: Acquired immune deficiency syndrome 
Agr: Accessory gene regulator 
BHI: Brain heart infusion 
CC: Clonal complex 
CDC: US Center for disease control and prevention 
CDDEP: The center for disease dynamics, economics & policy 
CF: Cefoxitin 
Cfr: Chloramphenicol/florfenicol resistance  
CFU: Colony forming unit 
CoNS: Coagulase negative staphylococci 
CS2: Complex synthetic medium 2 
FOM: Fosfomycin 
GFP: Green fluorescent protein 
HGT: Horizontal gene transfer 
LB: Lysogeny broth 
LRSA: Linezolid-resistance Staphylococcus aureus 
MGE: Mobile genetic element 
MIC: Minimal inhibitory concentration 
MLST: Multilocus sequence typing 
MRSA: Methicillin-resistant Staphylococcus aureus 
MSSA: Methicillin-susceptible Staphylococcus aureus 
NB: Nutrient broth 
OD: Optical density 
OX: Oxacillin 
PBP: Penicillin binding protein 
PBS: Phosphate-buffered saline  
PCR: Polymerase chain reaction 
PFU: Plaque forming unit 
PhLOPSA: Phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A 
antibiotics  
SCCmec: Staphylococcal cassette chromosome mec 
ST: Sequence type 
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TCS: Two-component system 
TSA: Tryptic soy agar 
TSB: Tryptic soy broth 
VRSA: Vancomycin-resistant Staphylococcus aureus 
VRE: Vancomycin-resistant Enterococci 
WHO: World health organization 
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Chapter 1 
General Introduction – Horizontal Gene Transfer in Bacteria.  
First evidence of natural transformation in Staphylococcus aureus 
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1.1 Staphylococcus aureus – The leading cause of nosocomial infection 
Staphylococccus aureus belongs to Firmicutes group of Gram-positive bacteria. Its 
natural habitats are the skin and nasal cavity of human and warm-blooded animals. This 
bacterium is known as a commensal as well as opportunistic pathogen. S. aureus can cause 
a broad spectrum of infectious diseases, ranging from food-poisoning and superficial skin 
abscess to more life-threatening diseases such as bacteremia, osteomyelitis, endocarditis, 
and toxic shock syndrome. The number of deaths caused by S. aureus bacteremia alone is 
greater than total deaths caused by AIDS, tuberculosis and hepatitis infection [1]. In the 
most recent worldwide estimation published by the World Health Organization (WHO) in 
2014, S. aureus is among the top three greatest antimicrobial resistance concerns associated 
with both hospital-and community-acquired infections [2] 
 
1.2 Drug resistance in S. aureus 
Treatment of S. aureus infection has been difficult due to multidrug-resistance 
strains. Methicillin-resistant Staphylococcus aureus (MRSA) is the commonly isolated 
antibiotic-resistant pathogen in the hospitals and community [3]. MRSA rates exceed 20 
percent in most of the regions and above 80 percent in some regions (WHO Report, 2014). 
The increase and spread of MRSA and other resistant S. aureus strains such as vancomycin 
resistant S. aureus (VRSA) and linezolid resistant S. aureus (LRSA) with high burden in 
mortality and morbidity are major concerns of staphylococcal infection.  
S. aureus has an extraordinary ability to rapidly develop resistance (Figure 1-1). It 
has acquired resistance to almost all antibiotics that have been developed, ranging from 
penicillin which was introduced in the early 1940s to the more recent drugs such as 
linezolid, daptomycin, and ceftaroline (the fifth-generation of cephalosporin) [4], [5], [6], 
[7].  
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1.3. Mechanisms of drug resistance in S. aureus 
Mechanisms of resistance to major antibiotics used for S. aureus treatments are 
summarized in Table 1-1. Resistance mechanisms in S. aureus include enzymatic 
inactivation of antibiotics (β-lactamase [8], aminoglycoside-modifying enzymes [9]), 
alteration of the target to reduce the affinity to the drugs (penicillin-binding protein PBP2a 
[10], D-Ala-D-Lac [11]), trapping the antibiotics (vancomycin intermediate resistance 
[12]), efflux pumps (tetracycline [13], fluoroquinolone [14], and so on [15], [16]. These 
mechanisms are associated with either intrinsic way by modifying the bacterial genes or 
extrinsic way through the acquisition of genes responsible for the resistance. The later route 
is predominant and plays the major role in the resistance evolution in S. aureus (Table 1-1). 
Indeed, genome sequence studies revealed that S. aureus carries many resistance and 
virulence genes located in mobile genetic elements (MGEs) including plasmids, 
transposons, insertion sequences, bacteriophages, pathogenicity islands and staphylococcal 
cassette chromosomes (SCC) [17]. The presence of these elements in the genome of S. 
aureus indicates that the acquisition and transfer of genetic materials play an important role 
for the adaptation and evolution of S. aureus. 
 
1.4. Horizontal gene transfer in bacteria and S. aureus 
Transfer of genetic materials between organisms is known as horizontal gene transfer 
(HGT) or lateral gene transfer, which is distinct from the transfer between parent-offspring 
relationship, the vertical gene transfer. There are three major HGT mechanisms in bacteria: 
conjugation, transduction and transformation [18, 19] (Figure 1-2). 
Conjugation is a process involving the transmission of DNA from one living cell to 
another. Both cells must be in direct contact, allowing the DNA to be protected by special 
structures such as tubes or pores [20]. Conjugation occurs in S. aureus, but it requires a 
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series of tra genes or conjugative plasmids, which are not widespread among S. aureus 
strains [21], [22], [23].  
Phage transduction is the transfer of DNA through the bacteriophage (phage). 
Transduction is though to be more predominant, since most of S. aureus isolates are 
lysogenized by bacteriophages [24]. Phage transduction in S. aureus, however, is limited to 
transfer of small DNA fragments (less than 45 kb) due to the size of phage capsid. Also, S. 
aureus phages are particularly host specific [25].  
Transformation is a process to actively acquire free DNA in the environment by the 
bacterial cell. To uptake extracellular DNA, bacterial cell needs to develop a special 
physiological phase: the competence stage. When the stage is reached, competent cells are 
capable of transporting DNA into the cytoplasm, acquiring new genetic traits. It had long 
been the question whether S. aureus was able to develop competence for transformation. A 
part of my previous study contributed to demonstrate the natural transformation in S. 
aureus for the first time [26]. 
Studies of transduction and conjugation have long history and useful review articles 
are available [24], [27], [21]. On the other hand, natural transformation was recently found, 
and the regulation of the competence development is distinct from other species. What was 
known for the natural genetic transformation in S. aureus is summarized in the following 
section. 
1.5. Natural competence and transformation in S. aureus 
Only small number of transformable species has been reported (approximately 0.02% 
among bacterial species) [28]. Unlike conjugation and transduction, transformation is 
entirely directed by the recipient bacterial cell. The cell develops the competence stage in 
which a series of membrane-associated and cytoplasmic proteins so called competence 
machinery are activated, allowing the uptake of foreign DNA into the cell. Studies in the 
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most well known transformable bacteria such as Streptococcus pneumoniae, Bacillus 
subtilis (Gram-positive bacteria) or Helicobacter pylori, Hemophilus influenza, Neisseria 
spp. (Gram-negative bacteria) have shown that these species share the conserved 
competence machinery for DNA uptake and processing [28]. However, the cues and 
regulation of competence for transformation are different among species [28]. The 
information obtained from previous studies also suggests the activation of competence 
could provide the benefit to the needs of each bacterium [29].  
Pseudo-competence in S. aureus was reported a few decades ago [30], but it requires 
phage tail [31], and was not the true competence [26]. However, S. aureus possesses the 
competence gene orthologues that share among transformable Gram-positive bacteria such 
as B. subtilis and S. pneumoniae [26]. The expressions of competence genes in S. aureus 
are induced by SigH [32]. SigH is one of the alternative sigma factors in S. aureus. It 
associates with the core RNA polymerase, and renders the resultant holoenzyme the ability 
to recognize the promoter sequence and initiate the transcription of competence genes. 
Overexpression of SigH induced the expression of comG operon (comGA, comGB, comGC, 
comGD, com GE, comGF) and comE operon (comEA, comEB, comEC) encoding for DNA 
binding, transport and uptake machinery [32], [26], and other competence genes (dprA, 
coiA) required for DNA recombination [33].  
The expression of SigH is in the minor population and undetectable during growth 
under standard laboratory growth conditions [26]. At least two distinct mechanisms 
regulating the expression of SigH was clarified. One is the spontaneous duplication of sigH 
locus that occurs at a low frequency (≤ 10-5) generating the chimeric sigH. The other 
involves the post-transcriptional regulation through an inverted repeat sequence upstream 
of sigH coding sequence, which suppresses the expression of SigH [26]. The limited SigH 
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expression could explain the difficulties to detect transformation through competence in S. 
aureus.  
The artificial overexpression of SigH does not make S. aureus transformable in 
normal growth conditions. The growth in a complete synthetic medium (CS2 medium) 
facilitates the transformation with the frequencies up to 10-8 ~ 10-9 when purified plasmids 
were used as donor DNAs and about 10-7 ~ 10-9 in the co-culture with the living donor cells 
[26]. Importantly, we could detect the transformation of the entire 53 kb type II 
Staphylococcal Cassette Chromosome mec (SCCmec) conferring the resistance to 
methicillin (Figure 1-3).  
In this thesis, the impact of transformation together with other HGT pathways in the 
spread of the emerging linezolid resistance in S. aureus was examined (Chapter 2). 
Furthermore, the factors affecting on transformation, here the effects of antibiotics, were 
examined to get insights into the regulation of competence and transformation in S. aureus.  
Summary of the studies and future directions on natural competence and transformation in 
S. aureus are discussed in the last chapter (Chapter 4). 
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Table 1-1. Mechanisms of resistance to major antibiotics in S. aureus  
 
Antibiotic class Target Resistance 
gene 
Gene product Mechanism of resistance MGE Reference 
Fluoroquinolones  
(ciprofloxacin, norfloxacin, 
levofloxacin, moxifloxacin) 
DNA 
replication 
gyrA, gyrB 
grlA, grlB 
norA 
GyrA, GyrB 
GrlA, GrlB 
NorA, efflux pump 
Mutations on drug target – decreased binding 
Active efflux 
 [34] 
[35] 
[14] 
Lipopeptides 
(daptomycin) 
Cell 
membrane 
mprF 
yycG 
rpoB, rpoC 
Phosphatidylglycerol lysyltransferase 
Two-component sensor kinase WalK. 
RNA polymerase 
Gene mutation. Change in cell membrane charge 
– decreased drug binding 
 [36] 
Oxazolidinones 
(linezolid) 
Translation rrn 
cfr 
Ribosomal RNA 
Methyltransferase 
Mutation of ribosome. Reduce the susceptibility 
Methylation of ribosome - decreased binding 
 
Plasmid 
[4]; [37]  
[38], [39] 
β-lactam 
(penicillins, methicillins, 
cephalosporins, 
carbapenems) 
Peptidoglycan 
synthesis 
blaZ 
mecA 
β-lactamase 
Penicillin-binding protein (PBP2a)  
Enzymatic hydrolysis of β-lactam  
Reduced affinity for PBP 
Plasmid 
Chromosome: 
SCCmec 
[8] 
[10] 
Chloramphenicol Translation cat Chloramphenicol acetyltransferase  Acetylation of drug – inactivation Plasmid [40] 
Tetracycline Translation tetK, tetL 
tetM, tetO  
Tetracycline efflux pump  
Tetracycline resistance protein 
 Active efflux 
 Ribosome protection – competitive binding 
Plasmid 
Plasmid 
[13] 
Macrolides and Lincosamides 
(erythromycin, clindamycin) 
Translation ermA, 
ermB, 
ermC 
Ribosomal methylase Methylation of ribosome – decreased binding Plasmid [41] 
Trimethoprism/Sulfamethoxazole Enzyme 
modification 
dhfr 
dhps 
Dihydrofolate reductase 
Dihydropteroate synthase 
Mutations on drug target – decreased binding Chromosome, 
Plasmid 
Chromosome 
[42] 
[43] 
Streptogramins 
(quinupristin/dalfopristin) 
Translation ermA, 
ermB, 
ermC,  
vat, vatB 
Ribosomal methylase 
Acetyltransferase  
Methylation of ribosome – decreased binding 
Acetylation of drug – inactivation 
Plasmid 
Plasmid 
[44] 
[45] 
Aminoglycosides 
(amikacin, gentamicin, 
tobramicycin, kanamycin, 
streptomycin) 
Translation aac,  
ant,  
aph 
Acetyltransferase 
Adenylyltransferase 
Phosphotransferase 
Aminoglycoside modifying enzymes – 
inactivation 
Chromosome, 
Plasmid 
[9] 
Glycopeptides 
 
Peptidoglycan 
synthesis 
vanA D-Ala-D-Lac Modified drug target - reduced affinity for 
vancomycin 
Chromosome, 
Plasmid 
[11] 
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Figure 1-1. First reported cases of bacterial resistance against key antibiotics. 
Data source: Antibiotic Resistance Threats in the United States, 2013, US Center for Disease Control and Prevention (CDC). 
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Figure 1-2. Three major horizontal gene transfer mechanisms in S. aureus. 
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Figure 1-3. Natural transformation of type II SCCmec. (A) Acquisition of drug 
resistance through the competence in S. aureus. Methicillin sensitive S. aureus (MSSA) 
overexpressing SigH were incubated with purified genome harboring SCCmecII from 
methicillin resistant S. aureus (MRSA). The transformant became resistant to β-lactam 
Cefoxitin (CF, left side) and Kanamycin (K, right side). (B) Long PCR analyses confirming 
transfer by transformation of the entire SCCmecII element in seven transformants where 
aadD and mecA were both present. Primer locations are shown on the SCCmecII map. All 
of the transformants gave signals with the expected size. Chromosomal DNA from strains 
N315 and N315ex-h was used for positive and negative controls, respectively. M: λHindIII, 
M2: 1 kb ladder [26].  
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Chapter 2  
Horizontal transmission of cfr gene to MRSA 
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2.1. Summary 
Linezolid resistance mediated by the cfr (chloramphenicol/florfenicol resistance) gene 
represents a global concern due to its dissemination among multidrug resistant nosocomial 
pathogens such as MRSA. This work aimed to clarify the potential of global transmission 
of cfr on the pSCFS7-like plasmids from two Staphylococcus epidermidis strains isolated 
in Spanish hospitals to various clinically isolated S. aureus strains in Japan in which cfr has 
not been detected. An efficient transfer of cfr was observed in this interspecies 
transmission. Furthermore, the transmission of cfr among S. aureus pool after acquiring the 
gene from S. epidermidis was investigated by addressing the three major pathways of 
HGT: conjugation, transduction and transformation. Even though conjugation is thought to 
be the main mechanism of cfr dissemination, transduction was found to be an alternative 
pathway for the transmission of cfr gene between S. aureus strains.  
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2.2. Introduction 
Linezolid is an oxazolidinone antimicrobial drug that is most effectively used in the 
treatment of resistant Gram-positive bacteria, including MRSA, VRSA, vancomycin 
resistant enterococci (VRE), and streptococci [46]. However, linezolid-resistant S. aureus 
(LRSA) was reported just one year after the drug was approved for clinical use [4]. Three 
major linezolid resistance mechanisms have been described. The first mechanism involves 
the mutations in the domain V region of the 23S rRNA, thus preventing the binding of the 
antibiotic. Second mechanism is related to the mutations or deletions in the ribosomal 
protein L3 and L4, reducing the binding to drug target. These mutations and deletions are 
often associated with the prolonged and/or intermittent use of linezolid [47]. The third 
mechanism is due to the acquisition of a plasmid-borne ribosomal methyltransferase gene, 
the cfr (chloramphenicol/florfenicol resistance). The methyltransferase encoded by cfr gene 
methylates the adenosine at position A2503 in 23S rRNA within the overlapping binding 
sites for phenicols, lincosamides, oxozolidinones, pleuromutilins and streptogramin A, 
resulting in the resistance to all of these antibiotics, known as PhLOPSA resistance 
phenotype [48], [49]. Even though the presence of cfr gene only slightly increase the 
minimal inhibitory concentration (MIC) to linezolid in the absence of ribosomal mutations, 
its ability to be transmitted between strains and species has raised a global concern [50].  
The cfr gene was initially described in a 16.5-kb transmissible plasmid (pSCFS1) 
from a livestock-associated Staphylococcus sciuri strain [51]. The cfr gene located in 
different types of plasmids was later detected in other staphylococcal species [52]. The first 
report of cfr gene isolated from S. aureus in a human patient sample in Columbia was 
described in 2005 [39]. Following this report, the cfr-associated linezolid resistances have 
been documented in clinical staphylococcal isolates and hospital outbreaks in different 
countries [53], [54], [55], [56], [57], [58], [59], [60]. The coagulase negative staphylococci 
(CoNS), in particular S. epidermidis, have been speculated as the reservoir of cfr gene for 
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the transmission to S. aureus and other pathogenic bacteria [61]. The cfr-positive CoNS are 
increasingly isolated in hospitals due to high consumption of linezolid. This entails the 
subsequent increase in the cfr-positive S. aureus strains, which are currently maintained at 
low frequencies [50]. In Japan, the resistance to linezolid in CoNS and S. aureus strains 
remains hitherto low. No cfr detection in clinical isolates has been reported [62]. In this 
situation, it is important to determine the risk of cfr dissemination among clinical isolates. 
Regarding to the mechanisms of dissemination, conjugation has been the only route 
demonstrated for cfr transmission.  
This work aimed to evaluate the ability of the transmission of cfr gene from two S. 
epidermidis strains isolated from Spanish hospitals to a series of clinically isolated S. 
aureus strains in Japan, and examine the HGT mechanisms involved in the further 
dissemination among S. aureus strains. The results showed a potential of global 
transmission of cfr from S. epidermidis to S. aureus; and demonstrated that in addition to 
conjugation, phage transduction could be responsible for the dissemination of cfr among S. 
aureus pool while natural transformation was unable to be detected in this transmission. 
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2.3. Materials and Methods 
Bacterial strains  
Bacterial strains used in this study are listed in Table 2-1. S. epidermidis strains were 
isolated in Spanish hospitals and stored in the reference collection of the Spanish National 
Center for Microbiology. The SE45 strain was isolated in Madrid and the SE50 was 
isolated in Andalucia region. Both strains belonged to the ST2 group (defined by 
multilocus sequence typing - MLST) and harbored the cfr gene on ~ 40 kb plasmids with a 
pSCSF7-like cfr insertion region, determined by mapping PCR (Figure 2-1).  
S. aureus clinical MRSA strains (n=16) were isolated from the Kanto area in Japan 
[63]. Most of the clinical isolates belonged to clonal complex 5 and all of them harbored 
the type II SCCmec (Table 2-1) defined by clonal complex designation and SCCmec 
typing, respectively, as described in the below. 
 
Clonal complex designation  
Clonal complex (CC) designation of S. aureus clinical isolates was performed 
following the method described by Cockfield et al., 2007 [64]. Three PCR assays were 
carried out to determine the CC type of each isolate. Each PCR containing one forward and 
two different reverse primers (Table 2-2). Chromosomal DNAs were extracted from the 
strains following the conventional whole DNA isolation method [65] and used as DNA 
templates for the PCRs.  
 
SCCmec typing  
A multiplex PCR to assign major SCCmec types for S. aureus was carried out as 
previously described method [66]. A QIAGEN multiplex PCR kit was used. Whole DNA 
extracts were used as DNA template for the PCR. Prototype strains used for SCCmec 
typing were COL (SCCmec I), N315 (SCCmec II), 85/2082 (SCCmec III), MW2 (SCCmec 
IV), and WIS (SCCmec V). The PCR products  (5 µL/each) were visualized using UV light 
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(FasIII UV Transilluminator, Toyobo) after electrophoresis in a 3% (w/v) agarose gel. 
 
Molecular analysis of cfr-carrying vectors  
Primers used in the molecular analysis of pSCFS7-like vectors are listed in Table 2-2. 
Amplifications were carried out in SE45, SE50 and their N315 cfr-positive derivatives 
(N315-45 and N315-50, see below). Amplification of traA and nes genes was performed 
using primers designed based on the pGO1 sequence (accession number FM207042) [67], 
which is considered as the prototype conjugative staphylococcal plasmid. Primers for 
backbone amplification of the cfr vectors were designed based on the available sequence of 
pSCFS7 vector p12-02300 (accession number KM521837) [59]. 
 
Conjugation 
Conjugative transfer of cfr-carrying plasmids was performed using filter-mating 
method described previously [68].  
Interspecies conjugation: S. epidermidis to MRSA 
SE45 and SE50 were used as donor strains. MRSA strains; N315, COL and their 
phage-cured derivatives (N315ex w/oϕ and COL w/oϕ) were used as recipients. The 
recipient strains used were chloramphenicol susceptible and erythromycin resistant, except 
COL and COL w/oϕ strains, which was chloramphenicol susceptible and tetracycline 
resistant. The susceptibility profile of recipient strains allowed the use of chloramphenicol 
(32 mg/L: to select cfr positives) plus erythromycin or tetracycline (32 or 8 mg/L 
respectively: to eliminate donor S. epidermidis) in the selection of transconjugants. 
Conjugation was performed following a previously described protocol [68] with a few 
modifications. Overnight cultures of the donor and recipient were prepared in Tryptic soy 
broth (TSB) medium with and without 32 mg/L chloramphenicol, respectively, with 
shaking at 37 °C. The cultures were adjusted to the optical density 1 (OD600 = 1) using 
fresh TSB medium. 0.5 mL of the donor (SE45 or SE50) was mixed with 0.5 mL of the 
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recipient and 1 mL of PBS. The mixture was transferred onto a 0.45-µm filter membrane 
using a vacuum pump system. The membrane was put on a sheep blood agar plate and 
incubated at 37 °C for 1 day. The membrane was collected and resuspended in 10 mL of 
phosphate-buffered saline (PBS) by vortex. One hundred µL of the 10-4 diluted samples 
were plated on TSB agar (TSA) plates supplemented with 32 mg/L chloramphenicol plus 
erythromycin or tetracycline (32 or 8 mg/L, respectively: to eliminate donor S.epidermidis) 
in the selection of transconjugants. Another one hundred µL of the diluted suspension (10-5-
10-6) were plated onto TSA plates with erythromycin (32 mg/L) or tetracycline (8 mg/L) 
alone to count the total number of recipients. The plates were incubated at 37 °C for 18-24 
h. Double-resistant colonies obtained in the interspecies (S. epidermidis to MRSA) 
transmission experiments were confirmed by plating on mannitol salt agar (S. aureus is 
positive while S. epidermidis is negative in mannitol utilization), and detection of the cfr 
gene by PCR (Table 2-2).  
N315-45 and N315-50 derivatives were obtained by filter mating using as donors 
SE45 and SE50 strain, respectively. These cfr-positive strains were subsequently used in 
the characterization of pSCFS7-like vectors. 
 
Intraspecies conjugation: MRSA-to-MRSA 
For intraspecies conjugation between S. aureus strains, N315-45, COL-45, N315ex 
w/oϕ-45, COLw/oϕ-45 cfr-positive derivatives (obtained by filter-mating using as donor 
SE45), the T-N315-45 cfr-positive transductant strain (obtained by phage transduction) and 
their original cfr-negative strains were used as donor and recipient respectively. Putative 
transconjugants were confirmed by checking the antibiotic susceptibility profile and 
detection of the cfr gene by colony PCR. 
 
Phage transduction 
The bacteriophage MR83a (laboratory stock) is a staphylococcal transducing phage, 
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belonging to Siphoviridae family, suitable for transduction from/to N315 [69]. First, phage 
MR83a was used to infect the N315-45 transconjugant strain. The resultant phage pool 
(MR83a-45) was harvested and used to test the transmission of cfr gene by generalized 
transduction. One mL of the phage pool (2 x 1012 plaque forming unit pfu/mL) was mixed 
with 0.5 mL of recipient strains (N315, COL or Mu50) overnight-cultured in nutrient broth 
(NB, Oxoid) supplemented with 3.6 mM CaCl2 (NBCaCl2). The mixture was incubated at 
37oC for 30 min. After the addition of 0.1 mL of 20% sodium citrate, the mixture was 
further incubated for 30 min. Transductants were selected in brain heart infusion (BHI)-
agar medium supplemented with 32 mg/L chloramphenicol. Putative transductants were 
confirmed by assessment of recipient susceptibility profile and detection of the cfr gene by 
colony PCR.  
 
Natural transformation 
A natural competent strain derived from N315 (N2-2.1) was used as the recipient in 
this study. N2-2.1 carries a sigH locus duplication that constitutively expresses the sigH 
fusion gene, rendering this strain naturally competent [26]. Donor DNA in transformation 
experiments was obtained from the COL-45 transconjugant strain. Plasmid purified by 
QIAfilter plasmid Midi kit (QIAGEN) or whole DNA prepared by conventional 
purification method [65] was used as the source of cfr in these experiments. Transformation 
of pT181 and pHY300PLK plasmids, purified from COL and E. coli HST04 dam-/dcm- 
(Takara) respectively, was performed in parallel as the positive control. Transformation 
assay was carried out using a previously described method [26]. Briefly, 0.5 mL of 
overnight culture of N2-2.1 in TSB supplemented with chloramphenicol  (12.5 g/L) was 
precipitated by centrifugation (10,000 x g for 1 min at 4 °C). Cells were resuspended into 
10 mL of CS2 medium. The bacteria were grown at 37 °C with shaking (180 rpm) until the 
late exponential phase (about 8 h). Cells were harvested and resuspended in 10 mL of fresh 
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CS2 medium. Ten 10 µg of purified plasmid or genomic DNA was added to the cell 
suspension and continuously grown for 2.5 hours. After centrifugation, cells were 
resuspended in 10 mL of BHI medium and mixed with 90 mL of melted BHI agar (kept 
warm at 55 °C) supplement with 32 mg/L chloramphenicol (or 5 mg/L tetracycline in the 
control experiment). Pour the mixture into the 90-mm petri dishes and incubate the plates at 
37 °C for 2 days. Generated colonies (transformants) were confirmed the acquired 
resistance gene (cfr or tetM) by colony PCR. 
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2.4. Results 
2.4.1. Conjugative transmission of cfr from S. epidermidis to MRSA 
In the first transmission experiment, the interspecies transmission of cfr from S. 
epidermidis strains (SE45 and SE50) to MRSA strains was investigated. The data are 
summarized in Figure 2-2. The SE45 strain was able to transfer cfr gene to all tested S. 
aureus strains with a mean frequency of 8.57 x 10-5 transconjugants per recipient cell. In 
contrast, transfer of cfr from SE50 could only be detected in half of the recipient strains and 
the frequency of transmission was lower (mean 5.21 x 10-9). The results indicate that 
frequency of cfr transmission depends on background of the donors. 
Next, the existence of the conserved conjugative element (tra) and the associated 
nickase gene (nes) in the S. epidermidis donors (SE45, SE50) and the S. aureus 
transconjugants (N315-45, N315-50, respectively) was analyzed by PCRs. Negative 
amplification was observed in case of SE45, whereas positive amplification results for both 
genes were obtained in the SE50 strain (Figure 2-3). Negative amplifications were obtained 
in both N315-45 and N315-50, indicating the absence of these genes in SE45 and SE50 
pSCFS-7 like vectors. To determine the structural similarity of the SE45 and SE50 pSCFS-
7 like plasmids to the recently reported cfr-carrying plasmid, the p12-02300 [59], a set of 
primers located outside the cfr insertion context was designed based on the available p12-
02300 sequence. Amplifications were tested in SE45, SE50, N315-45 and N315-50 strains. 
Amplifications gave expected size products in the four strains (Figure 2-4) suggesting the 
backbone similarities between SE45 and SE50 plasmids and p12-02300.  
 
2.4.2. S. aureus can transfer cfr by conjugation  
The cfr transmission between S. aureus strains was further investigated. The cfr-
positive S. aureus strains, N315-45 and COL-45 obtained from the interspecies conjugative 
transmission described above were used as cfr donors in the conjugation to COL and N315 
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respectively. As shown in Figure 2-5A, N315-45 and COL-45 were able to further transfer 
the cfr to COL and N315 by filter-mating method indicating that these strains retained the 
transmission ability after they had acquired it from S. epidermidis.  
To exclude the possible involvement of other HGT pathways in this transmission, a 
set of intraspecies conjugative experiments were performed in the absence of native phages 
and competence machinery. Phage cured strains N315ex woϕ-45 and COL woϕ-45, were 
used as donors, while their original cfr-negative strains were used as recipient. We 
observed a similar transconjugant generation in these transmission (Figure 2-5B) showing 
that residence phages might not involve in the transmission of cfr-carrying vectors by 
conjugation. In the absence of competence components, the comG operon deletion mutant 
derived from N315ex woϕ (N315ex woϕ ΔcomG) was used as recipient; COL woϕ-45 
strain was used as donor in this conjugative experiment. As shown in Figure 2-5B, no 
significant difference in the transconjugant generation was obtained in this case. Thus, the 
result suggests the absence of transformation event in the filter-mating conjugative 
experiments. 
 
2.4.3. Phage-mediated transmission of cfr among S. aureus 
In S. aureus, phage transduction is thought to play a major role in HGT, since most of 
S. aureus isolates carry prophage in their genome. The DNA size which can be packaged 
by staphylococcal phage transduction is up to ~ 45 kb. Thus, the pSCFS-7 like vectors (~ 
40 kb) was expected could be transferred by phage transduction. The potential transmission 
of cfr gene by transduction was tested by using a staphylococcal transducing phage MR83a 
(see Materials and methods). First, phage MR83a was amplified by infecting the N315-45 
to generate the cfr-packaged phage MR83a (MR83a-45). Phage MR83a-45 was then used 
to infect S.aureus strains N315, COL and Mu50. The transduction of cfr gene was observed 
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in all strains tested as shown in Table 2-3. The results indicate that phage transduction 
could contribute to the spread of cfr among S. aureus pool.  
To further evaluate the contribution of transduction in the spreading of cfr gene, the 
cfr-acquired N315 transductant strain obtained from transduction experiment (T-N315-45) 
was investigated. This strain was analyzed to determine the integrity of pSCFS7-like 
plasmid after transduction, as well as its conjugative ability. Analyses of the genetic 
environment of cfr insertion (Figure 2-1) and the plasmid backbone (Figure 2-6) by PCRs 
showed an indistinguishable amplification pattern between SE45, N315-45 and T-N315-45. 
The results showed the transmission of complete pSCFS7-like plasmid by phage 
transduction. Checking for its further transmission ability showed a comparable 
transconjugant generation to that previously obtained in the case of transmission from 
N315-45 to COL in the conjugative experiments (Figure 2-5A). Thus, these data suggest 
the retention of conjugative capability of pSCFS7-like plasmid after phage transduction. 
 
2.4.4. Natural transformation of cfr 
The involvement of natural transformation in the transmission of cfr among S. aureus was 
evaluated. A native SigH-active strain constitutively expressing SigH (N2-2.1) was used as 
recipient in the transmission. Purified plasmid or whole DNA extracts from COL-45 strain 
was used as cfr donor (see Materials and methods). As shown in Table 2-3, no cfr 
transformant was observed in our experimental condition, while transformation frequencies 
of pT181 and pHY300PLK plasmid was at 10-9 ~ 10-10. The results suggest a low relevance 
of transformation in the dissemination of cfr among S. aureus strains.  
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2.5. Conclusions and Discussion 
In this study, the cfr transmission to S. aureus from the CoNS species (S. 
epidermidis) was confirmed. Moreover, different HGT pathways involved in the 
dissemination of cfr among S. aureus pool were investigated. The results showed that the 
cfr-carrying pSCFS7-like plasmids in SE45 could be efficiently transferred from S. 
epidermidis to various clinically isolated S. aureus. The efficiency of the transmission 
depended on the characteristics of the donor (Figure 2-2). Of concern, after acquisition, the 
pSCFS7-like plasmid could further spread to other S. aureus strains by different HGT 
routes (Table 2-3). Even though conjugative transmission has been thought to be the only 
way for cfr spreading, here the contribution of phage transduction was demonstrated. To 
our knowledge, this is the first report of a conjugation-independent HGT mechanism of the 
cfr gene in S. aureus. Importantly, the pSCFS7-like plasmid was entirely transduced by 
phage transduction and retained the conjugative ability of the plasmid for further 
transmission (Figure 2-1, Figure 2-6 and Figure 2-5). No transformation of the cfr gene was 
observed in the employed condition, suggesting a low relevance of natural transformation 
in the spread of pSCSF7-like plasmid. The reason for the failure to detect the pSCSF7-like 
plasmid transformation might be attributed to its large size (~ 40 kb) compared to other 
plasmids (pT181, 4.4 kb and pHY300, 4.9 kb) that have been transferred by transformation 
as described in this study and previous study [26]; transformation could be detected at a 
lower frequency when 0.1 µg of pT181 was used, less than 10-9 while 10 µg of the plasmid 
generated the frequency at ~ 10-8 (data not shown), but not for 10 µg of pSCSF7-like 
plasmid. There also remains a possibility that plasmid quality of the purified pSCSF7 was 
low due to its large size, and it is known that intact DNA topology is important for natural 
transformation in B. subtilis [70]. It must also be noted that the transfer of large MGE (a 53 
kbp SCCmec type II) is possible by transformation [26]. Plasmid transformation and 
chromosomal transformation utilizes distinct systems to be stably incorporated as the 
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genetic information into the recipient, where several factors differently participate in S. 
pneumonia: DprA-RecA facilitate homologous recombination, SsbA facilitates the plasmid 
transformation, SsbB stabilizes single strand DNA in both chromosomal and plasmid 
transformation, while the C-terminal region of SsbB stimulate the recombination [71]. 
Another point that needs to be discussed is that the transformation efficiency in the 
employed protocol was low, which might have made it difficult to properly evaluate the 
transfer of large MGEs. There remains a possibility that S. aureus becomes highly active in 
transformation in certain unknown conditions. Further investigation is necessary to find 
better conditions for transformation as discussed in Chapter 3.  
The cfr-carrying pSCFS7-like vector could be transferred to clinical S. aureus in 
Japan, a country in which this gene has not been yet detected. Therefore, surveillance for 
the cfr gene in both S. aureus and ‘reservoir’ species, i.e. CoNS, is important.  Particularly, 
S. epidermidis would be of great concern, because it is the major species carrying the cfr 
gene. 
In this work, the presence of the conjugative elements (traA and nes gene) in SE45, 
SE50, and in the cfr-acquired N315-45, N315-50 transconjugant was analyzed. The 
detection of these conjugative components in SE50 strain but not on its N315-50 derivative 
suggested that conjugative genes were not associated with the pSCSF7-like vector, but 
might be related to chromosomal or additional native conjugative plasmid in this strain. In 
addition, the absence of these conjugative genes in the SE45 strain suggests an alternative 
route of transfer of the pSCSF-7 like plasmid in the filter-mating transmission.  
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2.6. Tables and Figures 
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Table 2-1. Bacterial strains and bacteriophage used in this work 
Strain Species cfr CC assignment 
SCCmec 
type Reference or Source 
Bacteria	
SE45a S. epidermidis + 2  This study 
SE50a S. epidermidis + 2  This study 
r406a S. aureus (MRSA) - 5 II [63] 
r3a S. aureus (MRSA) - 5 II [63] 
r39a S. aureus (MRSA) - 5 II [63]	
r59a S. aureus (MRSA) - 5 II [63]	
r32a S. aureus (MRSA) - 5 II [63]	
r132a S. aureus (MRSA) - 5 II [63]	
r68a S. aureus (MRSA) - 5 II [63]	
r91a S. aureus (MRSA) - 5 II [63]	
r62a S. aureus (MRSA) - 5 II [63]	
r703a S. aureus (MRSA) - 5 II [63]	
r418a S. aureus (MRSA) - 5 II [63]	
r434a S. aureus (MRSA) - 5 II [63]	
r83a S. aureus (MRSA) - 5 II [63]	
r408a S. aureus (MRSA) - NT II [63]	
r2040a S. aureus (MRSA) - 5 II [63]	
r70a S. aureus (MRSA) - 5 II [63]	
N315a,b S. aureus (MRSA) - 5 II	 [17] 
N315-45b,d S. aureus (MRSA) + 5 
II	 Transconjugant N315 strain 
harboring cfr from SE45  
(This study) 
T-N315-45b S. aureus (MRSA) + 5 II	 Transductant strain harboring cfr from N315-45 through phage 
MR83a (This study) 
N315-50 S. aureus (MRSA) + 5 II	 Transconjugant N315 strain harboring cfr from SE50  
(This study) 
N315ex w/of-45b	 S. aureus  + 5 - 
Transconjugant  N315ex 
w/of strain harboring cfr from 
SE45 (This study) 
N315ex w/of	ΔcomGb	 S. aureus - 5 - [72] 
N2-2 S. aureus - 5 - SigH active derived from N315, natural competent strain [26] 
N2-2.1c S. aureus - 
5 - N2-2 derivative, reporter plasmid 
cured (This study) 
COLa,b,d S. aureus (MRSA) - 8 I [73] 
COL-45b,c,d S. aureus (MRSA) + 8 I 
Transconjugant COL strain 
harboring cfr from SE45  
(This study) 
COLw/ofa,b	 S. aureus (MRSA) - 8 I Phage cured COL strain [26] 
COLw/of-45b	 S. aureus (MRSA) + 8 I 
Transconjugant COL w/of strain 
harboring cfr from SE45  
(This study) 
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a: strains used in cfr-conjugation experiments (S. epidermidis-to-MRSA) 
b: strains used in cfr-conjugation experiments (MRSA-to-MRSA) 
c: strains used in cfr-transformation experiments 
d: strains used in cfr-transduction experiments 
NT: not typeable 
T-COL-45 S. aureus (MRSA) + 8 I 
Transductant COL strain harboring 
cfr from N315-45 through phage 
MR83a (This study) 
Mu50d 
S. aureus (MRSA, 
VISA) - 
5 II [17] 
T-Mu50-45 S. aureus (MRSA, VISA) + 5 II 
Transductant Mu50 strain 
harboring cfr from N315-45 
through phage MR83a (This study) 
Bacteriophages 
MR83ad Siphoviridae family    [69] 
MR83a-45d Siphoviridae family  
  Phage obtained after the infection 
of N315-45 strain (This study) 
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Table 2-2. Oligonucleotides used in this study 
 
 
Product or region Primer Sequence (5’ à 3’) 
Annealing 
temperature 
Amplicon size 
(bp) 
Reference  
cfr 
cfr-fw TGAAGTATAAAGCAGGTTGGGAGTCA 
58ºC 746 [52] 
 
cfr-rv ACCATATAATTGACCACAAGCAGC  
pSCFS7 mapping  
tnpB-fw GGAACAGTGATAAGCCGGATG 
56ºC 4000 [52] 
 
tnpB-rv ACATGGTCCTGCAATTACTGGTA  
1F  TTGCGAAATGGGAAGAGGTAT 
56ºC 743 This study 
 
1R  TCGCATTGGTTATTTGTTTTATTC  
cfrR-F2 CTGCTTGTGGTCAATTATATGGT 
56ºC 681 This study 
 
bin3R AGGGTCTACTCTAATCAAACATAA  
traA 
traAF 
traAR 
AATGGCCGAAGATAGAGAGGA 
56ºC 557 This study 
 
TTGCTATTTGTCCCGAGGCG  
nes 
nesF ATCATTGAATCTAGCCCAGCA 
56ºC 380 This study 
 
nesR GGCACAGAAAACACGCTTGA  
b1  
(28064-32584)* 
b1F TCGGAACTCCAATCGCAAGAA 
56ºC 4521  This study 
 
b1R GCCCCCTGATCGTCCTTTAT  
b2  
(4490-8343)* 
b2F AGTGACGCGCAAGAACAGTA 
56ºC 3854 This study 
 
b2R TTTCCAGGCCTCGTCAAGTC  
b3  
(36848-612)* 
b3F 
b3R 
CGCAATTGGAGATCAGCACG 
56ºC 2648 This study 
 
GCAAGAATTGCACCAGCGAT  
CC typing AF AGGGTTTGAAGGCGAATGGG 
55oC 
  [64]  
 AR30 CAACAGAATAATTTTTTAGTTC 203 (with AF)    
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 AR22 TCAGAGCTCAACAATGATGC 990 (with AF)   
 AR45 GGAGCATTATCTGGTGTTTTCC 722 (with AF)   
 AR1 GGGTTGCTCCTTGCATCATA 1037 (with AF)   
 BF CCCAAAGGTGGAAGTGAAAA    
 BR8 CCAGTTGCACCATAGTAAGGGTA 680 (with BF)   
 BR5 TCGTCCGACTTTTGAAGATTG 1071 (with BF)   
SCC typing  
 
Type I-F 
Type I-R 
GCTTTAAAGAGTGTCGTTACAGG 
57ºC 
 613 
[66] 
 
GTTCTCTCATAGTATGACGTCC  
 Type II-F GATTACTTCAGAACCAGGTCAT 
287 
 
 Type II-R TAAACTGTGTCACACGATCCAT  
 Type III-F CATTTGTGAAACACAGTACG 
243 
 
 Type III-R GTTATTGAGACTCCTAAAGC  
 Type IVa-F GCCTTATTCGAAGAAACCG 
776 
 
 Type IVa-R CTACTCTTCTGAAAAGCGTCG  
 Type IVb-F AGTACATTTTATCTTTGCGTA 
1000 
 
 Type IVb-R AGTCATCTTCAATATGGAGAAAGTA  
 Type IVc-F TCTATTCAATCGTTCTCGTATT 
677 
 
 Type IVc-R TCGTTGTCATTTAATTCTGAACT  
 Type IVd-F AATTCACCCGTACCTGAGAA 
1242 
 
 Type IVd-R AGAATGTGGTTATAAGATAGCTA  
 Type IVh-F TTCCTCGTTTTTTCTGAACG 
663 
 
 Type IVh-R CAAACACTGATATTGTGTCG  
 Type V-F GAACATTGTTACTTAAATGAGCG 325  
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 Type V-R TGAAAGTTGTACCCTTGACACC  
 mecA-F TCCAGATTACAACTTCACCAGG 
162 
 
 mecA-R CCACTTCATATCTTGTAACG  	
* Numbers correspond to the available p12-02300 plasmid sequence (accession number KM521837). 
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Table 2-3. HGT mechanisms involved in cfr transmission in S. aureus strains 
 
HTG Donor Recipient Frequency  
Conjugation N315-45 COL 1.00 x10
-6 
N315-45 Mu50 1.29 x10-5 
Transduction 
N315-45 N315 6.88 x10-10 
N315-45 COL 1.00 x10-11 
N315-45 Mu50 3.68 x10-10 
Transformation plasmids (COL-45) N2-2.1 
ULD* 
whole DNA (COL-45) N2-2.1 ULD 
* ULD: under the limit of detection 
 
The frequency is expressed as transconjugants/recipient cell in conjugation experiments, whereas it is 
expressed as transductants/pfu in transduction experiments. The values correspond to average data obtained 
from two independent experiments.  
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Figure 2-1. Molecular characterization of representative pSCFS7-like plasmid of S. 
epidermidis strains. A: The S1 nuclease PFGE assay and hybridization with cfr probe 
performed on SE45 strain showed cfr gene located on a ca. 40 kb plasmid. B: Scheme of 
mapping PCR used for pSCFS7 genetic environment determination. C: Amplification of cfr 
genetic environment of N315-45 (cfr-positive transconjugant strain obtained in filter 
mating experiments using as donor SE45), T-N315-45 (cfr-positive transductant strain 
obtained cfr by transduction from N315-45 through MR83a phage), SE45 (clinical S. 
epidermids cfr-positive) and N315 (cfr-negative strain). 
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Figure 2-2. Interspecies dissemination of cfr from S. epidermidis to S. aureus obtained 
in filter-mating experiments. Two clinical cfr-positve S. epidermidis strains (SE45 and 
SE50) were used as donors. Clinical MRSA (n = 16), N315, COL and their phage-cured 
derivatives N315ex woϕ and COL woϕ were used as the recipients in these experiments. 
Representation of transconjugant generation is expressed as Log10transconjugants/mL. 
Average data obtained from two independent experiments are shown with SD. Black bars 
represent values of SE45 transmission; while bars represent values of SE50 transmission.  
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Figure 2-3. Amplification of the conserved conjugative elements traA and nickase 
(nes) in the two S. epidermidis strains (SE45 and SE50) and their transconjugants (N415-45 
and N315-50) obtained in filter-mating experiments.  
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Figure 2-4. Amplification of the pSCFS7-like plasmid backbone in the two S. 
epidermidis strains (SE45 and SE50) and their transconjugants (N415-45 and N315-50) 
obtained in filter-mating experiments.  
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Figure 2-5. Intraspecies dissemination of cfr from MRSA to MRSA in the presence 
(A) and absence (B) of bacteriophage and competence genes obtained in filter-mating 
experiments. All donor strains harbor the pSCSF-7 like plasmid from the SE45. (A) 
Transmission results obtained from the unmodified N315 and COL cfr-positive strains. 
N315-45 and COL-45 acquired by conjugation from SE45; T-N315-45 acquired cfr by 
transduction from N315-45 through the MR83a phage. (B). Transmission results obtained 
using N315 and COL phage-cured strains.  N315ex woϕ-45 and COL woϕ-45 acquired cfr 
by conjugation from SE45. N315ex woϕ ΔcomG is a DNA uptake defective mutant derived 
from N315ex woϕ. The values corresponding to average data of two independent 
experiments are shown with SD.  
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Figure 2-6. Backbone similarity amplifications of N315-45 (cfr-positive transconjugant 
strain obtained in filter mating experiments using as donor SE45), T-N315-45 (cfr-positive 
transductant strain obtained cfr by transduction from N315-45 through MR83a phage), 
SE45 (clinical S. epidermidis cfr-positive) and N315 strain. 
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Chapter 3 
Effects of antibiotics on transformation in SigH-expressing  
S. aureus 
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3.1. Summary 
Subpopulations of Staphylococcus aureus can develop competence for natural 
transformation in a manner dependent on SigH, which is an alternative sigma factor 
responsible for competence machinery expression. In addition to SigH expression, 
unknown environmental factors are thought to be required for natural transformation, 
because the transformation frequency in SigH expressing cells is variable depending 
on the culture conditions. In this chapter, I aimed to clarify the effects of antibiotics 
on transformation using S. aureus N315 carrying a sigH-expression vector. Cell wall-
affecting antibiotics such as bacitracin, fosfomycin and vancomycin, but not β-
lactams, increased the transformation frequency. Mitomycin C suppressed 
transformation. These results substantiate the involvement of additional factors, 
importantly cell wall affecting reagents, in the control of transformation, and also 
suggest that some antibiotics may induce staphylococcal horizontal gene transfer in 
the clinical settings.  
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3.2. Introduction 
In S. aureus, our group has revealed that competence is regulated by a transcriptional 
sigma factor – SigH, whose expression is tightly controlled to be expressed in only a minor 
population [26].  
In the competence-inducing CS2 medium, transformation frequency in the wild type 
strain is almost undetectable (<10-11) and was found to be low (~ 10-9) when SigH was 
overexpressed [26]. Considering that S. aureus has a prominent ability to quickly acquire 
resistance, there could be the favorable conditions to develop competence for 
transformation.  
Drug resistance is initially manifested in the setting where antibiotics constitute as 
selective pressure [74]. However, the effects of antibiotics on S. aureus transformation 
have not been explored yet. In this study, I investigated the effect of antibiotics used in the 
treatment of staphylococcal infection on the efficiency of transformation in SigH-
expressing cells. I found that antibiotics have distinct effects on transformation: antibiotics 
targeting on the bacterial cell wall modulate natural transformation, mitomycin C 
suppresses transformation. 
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3.3. Materials and methods 
Bacterial strains  
Bacterial strains and plasmids used in this study are listed in Table 3-1.  
 
Antibiotic susceptibility test 
Minimal inhibitory concentration (MIC) values of the antibiotics in TSB medium 
were determined by the microdilution method. A 96-well tissue culture test plate (TPP®, 
Zellkultur und Labortechnologie) inoculated with 5 x 104 colony forming unit (CFU)/well 
(100 µL) was incubated at 37oC for 18h. The antibiotics used in this study and their MIC 
values in TSB medium are described in Table 3-3.  
 
Natural transformation assay  
The strain N315ex w/oϕ h was used as the recipient. In this strain, the prophage was 
eliminated to exclude the possibility of “pseudo-competence” DNA transfer with the help 
of phage components, which is distinct from real competence [26]. SigH is expressed by a 
plasmid, pRIT-sigH [32]. The pRIT-sigH plasmid was also introduced into the competence 
deficient strains N315ex w/oϕ ΔcomG and N315ex w/oϕ ΔcomE by phage transduction to 
generate the SigH-overexpressing strains N315ex w/oϕ ΔcomG h and N315ex w/oϕ ΔcomE 
h (Table 3-1).  
Transformation assay was carried out as previously described with some 
modifications [26]. Briefly, glycerol stocks of S. aureus were inoculated in 5 mL of TSBcm 
and grown overnight at 37˚C with shaking 180 rpm. The overnight culture was diluted 20-
fold with fresh TSBcm (in 10 mL) and grown to mid-log phase (about 3 hours). Cells were 
then harvested by centrifugation (5000 rpm, 5 min) and suspended in fresh TSB with or 
without the antibiotics to be tested. After 5-hour incubation, cells were washed and 
replaced with fresh medium. Ten µg of unmethylated pHY300 (TetR) purified from 
Escherichia coli HST04 (dam−/dcm−) was added. Following 2.5 hour incubation at 37°C 
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with shaking, transformants were selected in BHI–agar medium supplemented with 5 mg/L 
tetracycline. A part of transformants was tested for the presence of tetR gene by colony PCR 
(Table 3-2). In line with our previous study [26], no spontaneous TetR mutant was detected 
throughout this study. The transformation frequency was calculated as the ratio of total 
number of transformants to the total viable cells after the antibiotics treatment and 
incubation with DNA. Total recipient cells were counted by plating a series dilution of the 
culture onto TSB-agar (TSA) plates.  
 
Mechanical and enzymatic disruption of cell walls 
Fastprep® device (MP Biomedicals) was used to physically disrupt the bacterial cell 
walls. A tryptic soy broth supplemented with 12.5 mg/L chloramphenicol (TSBcm) 
overnight culture was diluted 10-fold with fresh TSBcm (total 5 mL), and successively 
cultured for 8h. Cells were harvested, resuspendend in 0.4 mL TSB, and transferred to 2 
mL lysing matrix tube containing 0.1 mm silica beads (MP Biomedicals). The tube was 
shaken in Fastprep® device at 4 m/s for 10 s, 20 s and 30 s, once or twice, at 4˚C. After 
beating, cells were collected by centrifugation (10000 rpm, 10 min) and cell-bead mixture 
was resuspended in 1 mL TSB. The cell suspension was recovered in a new tube, and DNA 
was added to test the transformation frequency.  
For lysostaphin treatment, cells grown in 5 mL TSBcm were harvested at the mid-
log phase. Cells were then resuspended in 10 mL TSB medium containing lysostaphin at 
different concentrations and incubated for 5h at 37oC with shaking. After treatment, cells 
were washed and mixed with DNA for transformation.  
 
Statistical analysis 
Statistical analysis was carried out for the log values using Student’s t-test. 
  
 	 48 
3.4. Results 
3.4.1 Antibiotics have distinct effects on transformation in SigH expressing cell  
The effects of antibiotics on transformation were tested by at least 3 independent 
experiments (Figure 3-1). Bacitracin reproducibly increased the transformation frequency 
at low concentrations, but showed suppressive effect at higher concentrations. D-cycloserin 
showed no significant effect. Transformants were rarely detected in 1 mg/L cefazolin 
treatment (frequency 0.8 x 10-11, n = 1; none detected, n = 2). Oxacillin abolished 
transformation: no transformants were detected when cells were treated at ½ MIC of 
oxacillin. Mitomycin C suppressed transformation in a concentration-dependent manner. 
Ciprofloxacin, and norfloxacin that target on DNA gyrase had no significant effect. 
Streptomycin interfering the bacterial protein synthesis showed no effect on transformation.  
Vancomycin and fosfomycin increased the transformation frequencies (Figure 3-2A, 
2B), and the effects were statistically significant (P = 0.016, n = 9 for vancomycin; P = 
0.012, n = 10 for fosfomycin) (Figure 3-2C). SigH-expresing cells lacking the competence 
genes (N315ex w/oϕ ΔcomE h, N315ex w/oϕ ΔcomG h) generated no transformant in the 
presence of these antibiotics (n = 2), confirming that this is due to the transformation by 
natural genetic competence, rather than other horizontal gene transfer mechanisms. The 
transformation frequency in the presence of fosfomycin was highly variable depending on 
the experiment (Figure 3-2C). This variation might be due to the killing effect of 
fosfomycin (Figure 3-2B).  
 
3.4.2 Physical damages on the cell wall do not facilitate transformation in SigH-
expressing cells 
Increased transformation frequencies observed in several cell wall-targeting 
antibiotics suggested that cell wall integrity could be important for transformation. The 
Gram staining images of antibiotics treated cells indicated that treatment with some 
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antibiotics increases negatively stained subpopulation (red cells in Figure 3-3). However, 
the frequencies of the red subpopulation did not correlate with transformation frequencies, 
suggesting that the damages in cell wall alone cannot explain the increase in transformation 
frequencies. To test this implication, I examined the effect of cell wall damage by silica 
beads, and lysostaphin. 
First, the effect of physical disruption on the cell wall of SigH-overexpressing cell 
grown in TSB was tested using silica beads.	 CFUs were measured at different time points 
of bead beating to find the appropriate condition. Beating for 10 sec x 2, 20 sec x 2 and 30 
sec x 2 resulted in 30%, 45% and 60% reduction in CFU. None of the treatments improved 
the transformation efficiency (Figure 3-4A). 
I also tested the effect of lysostaphin, an enzyme that cleaves S. aureus cell walls 
[75]. As shown in Figure 3-4B, I did not observe any increase in the transformation 
frequency of TSB grown cells by lysostaphin treatment up to the concentration that reduced 
the CFU by half (0.1 mg/L). Higher concentrations of lysostaphin resulted in undetectable 
transformants due to cell death (Figure 3-4B).  
Taken together, these results indicate that external physical damages to the cell wall 
do not simply facilitate the transformation and suggested that certain complex cellular 
activity would be involved in the control of transformation.  
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3.5. Conclusions and Discussion 
Complex mechanisms participate in the control of natural transformation in a species-
specific manner, which has been well studied in the model bacteria such as Streptococcus 
and Bacillus. In S. aureus, we recently showed that SigH plays a key role in competence 
development, but many aspects of the regulation in competence development and the 
following transformation are not yet known. As part of the effort to gain insight into the 
regulation after SigH expression, we first showed the effects of antibiotics on 
transformation.  
 
I found that antibiotics targeting cell wall synthesis modulate transformation. The cell 
wall integrity or metabolism is known to be important in streptococcal transformation: the 
involvement of autolytic activity has been described in some species [76], [77], and the cell 
wall integrity can be an important signal that modulates transformation [78]. However, 
positive effects of bacitracin, vancomycin and fosfomycin are not simply caused by the 
damages in the cell wall as external physical damages to the cell wall by silica beads or 
lysostaphin did not facilitate the transformation. This suggests that effects of cell wall-
affecting antibiotics on transformation could be involved in certain cellular response. 
One important finding was that bacitracin facilitated transformation at a low 
concentration (1/20 of MIC). Utaida et al. previously reported the change in transcriptome 
in response to cell wall-affecting antibiotics, and found that 46 genes were up-regulated 
specifically by bacitracin. The most highly up-regulated gene was the ORF 1764 
(SACOL2727) encoding a putative integral recombinase [79], but the corresponding gene 
is missing in the N315 genome. Three genes in the lysine biosynthesis pathway were also 
up-regulated by bacitracin (dapB, dapB, and lysA); Lysine is a component of the cell wall, 
as well as the substrate to modify a phospholipid, phophatidylglycerol, affecting the net 
charge on the cell surface [80]. It is also known that bacitracin is sensed by the two 
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component system BraSR (or TCS17) together with the ABC transporter, BraDE [81]. 
Whether such bacitracin-related factors would be involved in the transformation regulation 
is an interesting question to be addressed in the future study. 
Treatment with β-lactam antibiotics could induce multiple responses. Antignac et al. 
showed that growing S. aureus in the presence of sub-inhibitory concentrations of β-lactam 
antibiotics provoked strong repression of the expression and activity of major autolytic 
enzymes [82]. On the other hand, β-lactams activate the SOS response [83], [84], [85]. Each 
response might interfere with transformation. Indeed, the involvement of autolytic activity 
in the induction of transformation has been described in some species [76], [77] whereas 
SOS response and transformation seem to be phenomena exclusive from each other [86]. 
SOS inducers such as fluoroquinolone or mitomycin C induce competence in species 
lacking the SOS system [87], [88], [89], but suppress competence in species harboring the 
SOS system [90]. Although the SOS response in S. aureus is more limited and its 
accessories are simple, it does exist [91], [92]. Our results showed that treatment with 
mitomycin C suppressed transformation in S. aureus (Figure 3-1E). However, the lack of 
effect of fluoroquinolone (ciprofloxacin and norfloxacin) (Figure 3-1F, 1G) might indicate 
the regulation is not so simple.  
 
Low concentrations of bacitracin are often combined with other antibiotics in triple-
antibiotic ointments used in the treatment of soft tissue infections [93]. Vancomycin 
remains an effective resource for MRSA treatment, though vancomycin resistant S. aureus 
has been reported [94]. Fosfomycin previously selected resistant staphylococci (fosfomycin 
resistant S. aureus increased in Japanese hospitals in 1980’s), but it is still among the 
choices for treatment, often in combination with other antibiotics [95]. The present study 
potentially raises a caution regarding medical prescription in the treatment of S. aureus 
considering the induction of HGT.  
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Mitomycin C showed an inhibitory effect on transformation frequencies in a dose 
dependent manner. Although the mechanism of how mitomycin C suppressed the 
transformation is unknown, the present finding indicates that some antibiotics currently 
used in hospitals could be applied for the control of natural transformation of S. aureus. 
Mitomycin C is mainly used as anti-cancer drug, but it has an inhibitory effect on bacteria. 
Notably, Kwan et al. proposed its effect on the “persister” S. aureus that is responsible for 
chronic infections, where prolonged contact with other resistant bacterial species might 
increase the chance of HGT under the selective pressures of prescribed antibiotics [96]. 
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3.6. Tables and Figures 
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Table 3-1. Bacterial strains and plasmids used in this study 
 
Strain Description Reference 
N315 pre-MRSA [97] 
N315ex SCCmec cured derivative of N315 [98] 
N315ex w/oϕ N315ex cured of the N315 prophage  [26] 
N315ex w/oϕ  h N315ex w/oϕ carrying pRIT-sigH (CmR) [26] 
N315ex w/oϕ ΔcomG ΔcomG mutant of N315ex w/oϕ [26] 
N315ex w/oϕ ΔcomG h N315ex w/oϕ ΔcomG pRIT-sigH (CmR) This study 
N315ex w/oϕ ΔcomE ΔcomE mutant of N315ex w/oϕ [26] 
N315ex w/oϕ ΔcomE h N315ex w/oϕ ΔcomE pRIT-sigH (CmR) This study 
E.coli HST04 dam-/dcm- 
pHY300 
E.coli HST04 dam-/dcm- (Takara) carrying tetracycline 
resistance pHY300 plasmid [26] 
Plasmids 
pHY300PLK Shuttle vector, ori-pAMa1, AmpR (E. coli), TetR (S. 
aureus) 
Takara, Japan 
pRIT-sigH SigH-expressing plasmid (CmR) [32] 
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Table 3-2. Oligonucleotides used in this study 
 
Primer name Sequence (5’ à 3’) 
IF-tet-I AGCCTGATAAAATACATCCTATTCACAAT 
IF-tet-II AATTCCGGAACTCTCTCCCAAAGTTGATC 
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Table 3-3. Characteristics of antibiotics used in this study 
 
Drug Target Effect MIC  
(mg/L) 
Fosfomycin UDP-N-acetylglucosamine-3-
enolpyruvyltransferase (MurA) 
Inhibits peptidoglycan synthesis  4 
Vancomycin D-alanyl-D-alanine moieties of the NAM/ 
(N-acetylmuramic acid NAG-peptides 
Inhibits peptidoglycan synthesis  4 
Bacitracin Undecaprenyl pyrophosphate (UPP), the 
lipid carrier  
Inhibits peptidoglycan synthesis 300 
D-Cycloserin D-Ala:D-Ala ligase A and alanine 
racemase 
Inhibits peptidoglycan synthesis 128 
Cefazolin Penicillin binding proteins (PBPs) Inhibits peptidoglycan synthesis 2 
Oxacillin  Penicillin binding proteins (PBPs) Inhibits peptidoglycan synthesis 1 
Mitomycin C DNA  Replication-fork stalling 1 
Ciprofloxacin DNA gyrase Replication-fork stalling 2 
Norfloxacin DNA gyrase Replication-fork stalling 4 
Streptomycin Ribosome 30S subunit Inhibits protein synthesis 16 
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Figure 3-1. Effects of antibiotics on transformation. N315ex w/oϕ h was exposed to 
different concentrations of antibiotics followed by the transformation with 10 µg of 
pHY300 plasmid. Bars: Log10 (transformation frequency); dotted lines: Log10 (CFU). 
Average values of at least three independent experiments are shown with SD. * P < 0.05 by 
Student’s T-test for log values of frequencies. MIC values of antibiotics were determined in 
TSB medium. ND: none detected. 
 
  
 	 59 
 
Figure 3-2. Effects of vancomycin (A) and fosfomycin (B) on transformation. (C) 
Repeated tests of the effects of vancomycin 2 mg/L (VCM2) and fosfomycin 3 mg/L 
(FOM3) on transformation frequencies are shown by box-plot. Boxes span the upper and 
lower quartile, lines inside the boxes indicate median, whiskers present the maximum and 
minimum values within the 1.5 quartile range, empty circles represent data points that are 
outside of this range. Control (no antibiotics), n = 10; VCM2, n = 9; FOM3, n = 10; * P < 
0.05. 
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Figure 3-3. Gram staining images of S. aureus (N315ex w/oϕ h) grown in TSB. (A) 
without antibiotics, (B) Fosfomycin 3 mg/L, (C) Vancomycin 2 mg/L, (D) Cefazolin 4 
mg/L, (E) Oxacillin 0.5 mg/L. Scale bars = 10 µm. (F) Average percentages of negatively 
stained cells (red cells) from two independent experiments. Spherical cells alone were 
counted, and red cell debris was excluded from the calculation. 
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Figure 3-4. Transformation frequencies in bead beating or lysostaphin treated cells. 
(A) Cells were treated by Fastprep system for the indicated time period prior to the 
transformation assay. (B) Cells were treated by lysostaphin. Mean and SD values are shown 
(n = 3). 
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 Chapter 4  
Summary and Perspective 
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The prominent evolutionary ability of S. aureus was evident from its history of the 
antibiotics resistance, which was further demonstrated by the genome sequencing study 
reported in 2001, where most of the virulence factors and antibiotics resistance genes were 
found in the MGEs [17]. For this reason, HGT ability of S. aureus has been a great concern, 
and each of the antibiotics resistance genes in distinct context of the MGEs were tested on 
their modes of transmission, as documented in a series of review articles and textbooks 
[99], [27], [25]. However, our knowledge had been limited to conjugation, transduction, 
and pseudo-transformation, because natural transformation was not known before 2012 
[26]. In this context, it is now critical to re-evaluate the evolutionary ability of S. aureus 
from the aspect of natural transformation. Aiming to start this effort, I examined the 
transmission mechanisms of the cfr gene. By testing three major HGT pathways including 
natural transformation, the relevance of two pathways was clarified. In future studies, 
similar efforts need to focus onto other resistance determinants to fully understand the 
overall characteristics of the staphylococcal evolutionary ability.  
 
As described before, the transformation efficiency in our first report was very low, 
and there remains the argument that the role of natural transformation would be quite 
limited in the evolution of S. aureus [25]. The bottleneck step(s) is still unknown: it can be 
DNA binding, internalization, double strand synthesis, or DNA recombination. It might 
also be the competence component(s) that are not regulated by SigH [32], [33] such as 
ComC (a signal peptidase that is indispensible for the maturation of the major pili 
ComGC), Com FA and ComFC (an ATP-binding protein and unknown function protein, 
respectively that are involved in the DNA transport across the membrane), and RecA (a 
protein required for homologous recombination). Tracking of competence developing steps 
can be addressed by observing the maturation of the competence machinery using 
immunofluorescence microscopy for the tagged components. With in this line, I have 
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prepared a series of strains carrying tagged competence genes, which will be useful for the 
future studies. 

It is also important to explore the unknown situation where S. aureus becomes highly 
transformable. This effort would be reasonable, because competence-inducing conditions in 
Gram-positive bacteria are diverse among species [28], and we might not know the bona 
fide stimuli to induce the transformation. In order to get insight into this question, one 
strategy we took was to test a series of conditions using SigH expressing cells. Previous 
efforts focused on distinct growth media, and found the specific complete synthetic 
medium (CS2 medium) was the most appropriate medium for transformation. Notably, in 
the CS2 medium, wild-type S. aureus N315 strain increases the percentage of the SigH 
expressing cells [26]. This indicates that certain conditions where the expression of the 
cryptic SigH factor is released might be preferable conditions for the process of natural 
transformation. Therefore, revealing the signaling mechanisms for SigH expression is also 
important to know the hidden conditions for the efficient transformation. Here, the 
involvement of a series of signal sensing molecules needs to be tested including the SigB 
general stress responsive system (SigB-RsbW partner switching mechanism that is 
regulated by upstream stress sensing complex [100]), the transcription factors that directly 
sense stimuli (e.g. PerR, a transcription repressor that can sense oxidative stress [101]), and 
the two-component systems (TCSs). TCSs play important roles to sense and regulate the 
expression of genes in response to environmental stimuli. TCS are composed of a sensor 
kinase (membrane sensor protein carrying cytosolic kinase domain) and a response 
regulator (transcription factor regulated by phosphorylation). In the regulation of natural 
competence, the involvements of TCS have been reported in some species [102], [103], 
[104], [105], [106]. S. aureus possesses 17 TCSs [17]. So far, we have successfully 
obtained deletion mutants for each of the TCSs from the N315ex woϕ as parental strain. 
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SigH activities in the TCS mutants can be measured by using a GFP reporter construct with 
SigH-dependent comG promoter [26]. Understanding the involvement of the specific 
TCS(s) in the control of competence would reveal the environmental cues affecting 
competence and transformation.  
 
A part of the efforts to find out the conditions in which transformation can be 
elevated, I found that antibiotics have the effects on transformation: cell wall-affecting 
antibiotics modulate transformation; mitomycin C suppresses transformation. Antibiotics 
were previously tested in S. pneumoniae showing that mitomycin C and other DNA 
replication inhibitors (ciprofloxacin and norfloxacin) induced the expression of the late 
competence gene (ssbB) while cell wall-targeting antibiotics (vancomycin and ampicillin) 
were not involved. Thus effects of antibiotics on transformation are distinct among species, 
probably reflecting the distinct cellular processes as discussed in the Chapter 3. Antibiotics 
inducing S aureus transduction have also been reported [107]. Thus, it seems to be general 
that antibiotics have effect on HGT in bacteria.  
Another interesting aspect would be to investigate the molecular basis of the interplay 
between natural transformation and other HGT pathways. Mitomycin C is often used to 
induce the lytic cycle from the lysogenic prophage, suggesting that it would induce the 
phage transduction, while suppressing the natural transformation. Previous studies showed 
that SigH plays a role in stabilizing the lysogenic state [108]. How HGT systems interact 
and control each other is also interesting question that must be addressed in future studies.  
 
The long-term goal in the studies of antibiotics resistance and their dissemination is 
to conquer the problem of antimicrobial resistance. To prevent and stop the dissemination 
of resistance, we need to take it into account not only the dissemination among human 
society, but also the livestock and the environment (“One health” concept) (CDC, 2016). 
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Indeed, in the case of S. aureus, vancomycin resistance is thought to be transferred via 
vancomycin-resistant enterococci (VRE) [109]. VRE was developed through the excess use 
of antibiotics in poultry farms around South-East Asia [110]. Linezolid resistance would be 
similar situation. CNS species found in livestock are considered as the genetic pool of the 
antibiotics resistance. In such a context, epidemiological efforts of comprehensive 
surveillance of resistance, politics to reduce the use of unnecessary antibiotics, and 
education of a broad range of specialists were proposed as the critical action plan to cope 
with this global issue. I have studied the HGT mechanism from the aspect of molecular 
genetics, but now we need to consider how we could contribute to this global effort.  In 
principle, we think conjugation and transduction can be blocked by inactivating the donor 
side, e.g. proper food cooking. However, free DNA alone can be the donor in the case of 
natural transformation, and to find how we could stop the DNA transformation would have 
significance. In this sense, the finding of the inhibitory effect of Mitomycin C was 
encouraging. 
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